How much dividend does Biotest pay?
Over the past 12 months, Biotest paid a dividend of 0.05 EUR . This corresponds to a dividend yield of about 0.12 %. For the coming 12 months, Biotest is expected to pay a dividend of 0.44 EUR.
Biotest Dividend 2024
Biotest Dividend
0 EUR
Biotest Dividend yield
0.12 %
Ticker
BIO.DE
ISIN
DE0005227201
WKN
522720
How much dividend does Biotest 2024 pay?
According to the latest status from November 2024, Biotest paid a total of 0 EUR per share in dividends within the last 12 months. With the current Biotest price of 41.4 EUR, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.
| 0.12 % Dividend Yield | = |
|
Historical Biotest Dividends
A dividend is paid times per year. Last year, the payout months were and .
| Paydate | Dividend |
|---|---|
| 10/1/2017 | 0.05 |
| 6/13/2016 | 0.02 |
| 6/8/2015 | 0.6 |
| 6/8/2014 | 0.57 |
| 6/9/2013 | 0.5 |
| 6/11/2012 | 0.44 |
| 6/13/2011 | 0.38 |
| 6/7/2010 | 0.34 |
| 6/8/2009 | 0.3 |
| 6/28/2008 | 0.3 |
| 6/4/2007 | 0.24 |
| 6/12/2006 | 0.12 |
| 6/23/2005 | 0.11 |
| 8/12/2002 | 0.25 |
| 8/13/2001 | 0.25 |
| 8/17/2000 | 0.2 |
| 8/16/1999 | 0.4 |
1
Biotest dividend history and estimates DE0005227201 · 522720
In 2023, Biotest paid a dividend amounting to 0 EUR. Dividend means that Biotest distributes a portion of its profits to its owners.
3 years
5 years
10 years
25 Years
Max
Dividend
Dividend (Estimate)
Details
Dividend
ⓘDividend Overview
The dividend per year chart for Biotest provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.
Interpretation and Use
A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Biotest’s potential for long-term investment and income generation through dividends.
Investment Strategy
Incorporate the dividend data in evaluating Biotest's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.
Biotest Dividend History
| Date | Biotest Dividend |
|---|---|
| 2026e | 2.07 undefined |
| 2025e | 0.44 undefined |
| 2024e | -0.03 undefined |
| 2017 | 0.05 undefined |
| 2016 | 0.02 undefined |
| 2015 | 0.2 undefined |
| 2014 | 0.19 undefined |
| 2013 | 0.17 undefined |
| 2012 | 0.15 undefined |
| 2011 | 0.13 undefined |
| 2010 | 0.11 undefined |
| 2009 | 0.1 undefined |
| 2008 | 0.1 undefined |
| 2007 | 0.08 undefined |
| 2006 | 0.04 undefined |
| 2005 | 0.04 undefined |
| Dividend | Dividend (Estimate) | |
|---|---|---|
| 2004 | 0 EUR | 0 EUR |
| 2005 | 0.04 EUR | 0 EUR |
| 2006 | 0.04 EUR | 0 EUR |
| 2007 | 0.08 EUR | 0 EUR |
| 2008 | 0.1 EUR | 0 EUR |
| 2009 | 0.1 EUR | 0 EUR |
| 2010 | 0.11 EUR | 0 EUR |
| 2011 | 0.13 EUR | 0 EUR |
| 2012 | 0.15 EUR | 0 EUR |
| 2013 | 0.17 EUR | 0 EUR |
| 2014 | 0.19 EUR | 0 EUR |
| 2015 | 0.2 EUR | 0 EUR |
| 2016 | 0.02 EUR | 0 EUR |
| 2017 | 0.05 EUR | 0 EUR |
| 2018 | 0 EUR | 0 EUR |
| 2019 | 0 EUR | 0 EUR |
| 2020 | 0 EUR | 0 EUR |
| 2021 | 0 EUR | 0 EUR |
| 2022 | 0 EUR | 0 EUR |
| 2023 | 0 EUR | 0 EUR |
| 2024e | 0 EUR | -0.03 EUR |
| 2025e | 0 EUR | 0.44 EUR |
| 2026e | 0 EUR | 2.07 EUR |
Is the Biotest Dividend Safe?
Biotest has been increasing the dividend for 2 years.
Over the past 10 years, Biotest has increased it by an annual 0 %.
Over a five-year period, the distribution increased by 0%.
Analysts expect a Dividend Cut of 0% for the current fiscal year.
Biotest dividend payout ratio DE0005227201 · 522720
In 2023, Biotest had a payout ratio of 29.53%. The payout ratio indicates the percentage of the company's profits that Biotest distributes as dividends.
3 years
5 years
10 years
25 Years
Max
Payout ratio
Details
Payout ratio
ⓘWhat is Yearly Payout Ratio?
The yearly payout ratio for Biotest represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.
How to Interpret the Data
A lower payout ratio for Biotest could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.
Using the Data for Investments
Evaluate Biotest's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.
Biotest Payout Ratio History
| Date | Biotest Payout ratio |
|---|---|
| 2026e | 29.26 % |
| 2025e | 29.25 % |
| 2024e | 28.99 % |
| 2023 | 29.53 % |
| 2022 | 29.23 % |
| 2021 | 28.21 % |
| 2020 | 31.15 % |
| 2019 | 28.33 % |
| 2018 | 25.15 % |
| 2017 | -55.56 % |
| 2016 | -1.72 % |
| 2015 | -9.57 % |
| 2014 | 39.99 % |
| 2013 | 19.84 % |
| 2012 | 15.6 % |
| 2011 | 9.74 % |
| 2010 | 11 % |
| 2009 | 13.89 % |
| 2008 | 13.89 % |
| 2007 | 17.39 % |
| 2006 | 8 % |
| 2005 | 9.34 % |
| 2004 | 25.15 % |
| Payout ratio | |
|---|---|
| 2004 | 25.15 % |
| 2005 | 9.34 % |
| 2006 | 8 % |
| 2007 | 17.39 % |
| 2008 | 13.89 % |
| 2009 | 13.89 % |
| 2010 | 11 % |
| 2011 | 9.74 % |
| 2012 | 15.6 % |
| 2013 | 19.84 % |
| 2014 | 39.99 % |
| 2015 | -9.57 % |
| 2016 | -1.72 % |
| 2017 | -55.56 % |
| 2018 | 25.15 % |
| 2019 | 28.33 % |
| 2020 | 31.15 % |
| 2021 | 28.21 % |
| 2022 | 29.23 % |
| 2023 | 29.53 % |
| 2024e | 28.99 % |
| 2025e | 29.25 % |
| 2026e | 29.26 % |
Dividend Details
Understanding Biotest's Dividend Distributions
Biotest’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining Biotest's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
Biotest's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in Biotest’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
Biotest Aktienanalyse
What does Biotest do?
Biotest AG is an innovative and successful company that operates in the fields of medicine, pharmacy, and biotechnology. It was founded in 1946 by Dr. Carl Adolf Vorherr in Dreieich near Frankfurt am Main. The company's original focus was on the development, production, and distribution of blood plasma products. In the 1950s, Biotest expanded into the field of transfusion medicine and began to clinically examine and process blood from donors. It became a leading manufacturer of concentrate preparations for the treatment of immune deficiencies and blood coagulation disorders in the 1960s. In the 1970s, the company became a leading manufacturer of monoclonal and polyclonal antibodies and an important research and development facility for biotechnological applications. Biotest today is divided into five research and business areas: Hematology & Immunology, Clinical Immunology, Biotherapeutics, Dermatology, and Research and Development. The company is globally present with locations in Europe, North America, Asia, and South America. It employs over 2,500 people and its products are available in more than 90 countries. It invests in research and development to stay at the forefront of technology and improve global health. Biotest is one of the most popular companies on Eulerpool.com.Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Frequently Asked Questions about Biotest stock
What is the dividend yield of Biotest?
The current dividend yield of Biotest is 0.12 %.
When does Biotest pay dividends?
Biotest pays a quarterly dividend. This is distributed in the months of June, June, June, September.
How secure is the dividend of Biotest?
Biotest paid dividends every year for the past 2 years.
What is the dividend of Biotest?
For the upcoming 12 months, dividends amounting to 0.44 EUR are expected. This corresponds to a dividend yield of 1.07 %.
In which sector is Biotest located?
Biotest is assigned to the 'Health' sector.
Wann musste ich die Aktien von Biotest kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Biotest from 9/4/2017 amounting to 0.05 EUR, you needed to have the stock in your portfolio before the ex-date on 8/31/2017.
When did Biotest pay the last dividend?
The last dividend was paid out on 9/4/2017.
What was the dividend of Biotest in the year 2023?
In the year 2023, Biotest distributed 0 EUR as dividends.
In which currency does Biotest pay out the dividend?
The dividends of Biotest are distributed in EUR.
Andere Kennzahlen von Biotest
Our stock analysis for Biotest Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biotest Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
